Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Journal of Zhejiang University. Science. B ; (12): 396-400, 2005.
Artículo en Inglés | WPRIM | ID: wpr-249200

RESUMEN

Plasmid vector is increasingly applied to gene therapy or gene vaccine. The production of plasmid pCMV-AP3 for cancer gene therapy was conducted in a modified MBL medium using a recombinant E. coli BL21 system. The effects of different MMBL components on plasmid yield, cell mass and specific plasmid DNA productivity were evaluated on shake-flask scale. The results showed that glucose was the optimal carbon source. High plasmid yield (58.3 mg/L) was obtained when 5.0 g/L glucose was added to MMBL. Glycerol could be chosen as a complementary carbon source because of the highest specific plasmid productivity (37.9 mg DNA/g DCW). After tests of different levels of nitrogen source and inorganic phosphate, a modified MMBL medium was formulated for optimal plasmid production. Further study showed that the initial acetate addition (less than 4.0 g/L) in MMBL improved plasmid production significantly, although it inhibited cell growth. The results will be useful for large-scale plasmid production using recombinant E. coli system.


Asunto(s)
Humanos , Acetatos , Farmacología , Carbono , Farmacología , División Celular , Medios de Cultivo , Química , Farmacología , ADN , Genética , Escherichia coli , Biología Celular , Genética , Terapia Genética , Vectores Genéticos , Genética , Nitrógeno , Farmacología , Fosfatos , Farmacología , Plásmidos , Genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA